ES382842A1 - Procedimiento para la preparacion de piperazinilalcohilami-no - uracilos, uracileteres y uraciltioeteres aril-sustitui-dos. - Google Patents

Procedimiento para la preparacion de piperazinilalcohilami-no - uracilos, uracileteres y uraciltioeteres aril-sustitui-dos.

Info

Publication number
ES382842A1
ES382842A1 ES382842A ES382842A ES382842A1 ES 382842 A1 ES382842 A1 ES 382842A1 ES 382842 A ES382842 A ES 382842A ES 382842 A ES382842 A ES 382842A ES 382842 A1 ES382842 A1 ES 382842A1
Authority
ES
Spain
Prior art keywords
uracil
uracils
thioethers
alkylamino
ethers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES382842A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda GmbH
Original Assignee
Byk Gulden Lomberg Chemische Fabrik GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chemische Fabrik GmbH filed Critical Byk Gulden Lomberg Chemische Fabrik GmbH
Publication of ES382842A1 publication Critical patent/ES382842A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/553—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/557—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms, e.g. orotic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
ES382842A 1969-08-20 1970-08-19 Procedimiento para la preparacion de piperazinilalcohilami-no - uracilos, uracileteres y uraciltioeteres aril-sustitui-dos. Expired ES382842A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1942405A DE1942405C3 (de) 1969-08-20 1969-08-20 Arylsubstituierte Piperazinylpropylenaminouracile

Publications (1)

Publication Number Publication Date
ES382842A1 true ES382842A1 (es) 1973-02-16

Family

ID=5743321

Family Applications (1)

Application Number Title Priority Date Filing Date
ES382842A Expired ES382842A1 (es) 1969-08-20 1970-08-19 Procedimiento para la preparacion de piperazinilalcohilami-no - uracilos, uracileteres y uraciltioeteres aril-sustitui-dos.

Country Status (24)

Country Link
US (2) US3957786A (es)
AT (2) AT302359B (es)
BE (1) BE755015A (es)
BG (3) BG17796A3 (es)
BR (1) BR6915466D0 (es)
CA (1) CA956944A (es)
CH (2) CH582173A5 (es)
DE (1) DE1942405C3 (es)
DK (1) DK124031B (es)
ES (1) ES382842A1 (es)
FI (1) FI54479C (es)
FR (1) FR2073300B1 (es)
GB (1) GB1309324A (es)
HK (1) HK23678A (es)
HU (1) HU163664B (es)
IE (1) IE35177B1 (es)
IL (1) IL35121A (es)
LU (1) LU61527A1 (es)
NL (1) NL155014B (es)
NO (1) NO129148B (es)
SE (1) SE386448B (es)
SU (1) SU399130A3 (es)
YU (2) YU36509B (es)
ZA (1) ZA705729B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2329399A1 (de) * 1973-06-08 1975-01-02 Wuelfing J A Fa 4-alkyl-aminouracile, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
LU74319A1 (es) * 1976-02-09 1977-08-19
DE3326118A1 (de) 1982-08-02 1984-02-09 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Pyridopyrimidintrione, verfahren zu ihrer herstellung, ihre verwendung und sie enthaltende arzneimittel
IE62890B1 (en) * 1988-12-06 1995-03-08 Hafslund Nycomed Pharma New piperazinylalkyl-3(2h)-pyridazinones process for the preparation thereof and the use thereof as agents lowering blood pressure
CA2024428A1 (en) * 1989-09-06 1991-03-07 Masayuki Ishikawa Agent for treating urinary obstruction
AU7078691A (en) 1990-02-01 1991-08-21 Byk Gulden Lomberg Chemische Fabrik Gmbh Use of urapidile and derivatives for treating arteriosclerotic diseases
DE4425143A1 (de) * 1994-07-15 1996-01-18 Basf Ag Substituierte Pyrimidinverbindungen und deren Verwendung
WO1996017831A1 (de) * 1994-12-07 1996-06-13 Byk Gulden Lomberg Chemische Fabrik Gmbh Uracilderivate
EP1604653A1 (en) 1998-09-30 2005-12-14 Takeda Pharmaceutical Company Limited Acetylcholinesterase inhibitors for improving excretory potency of urinary bladder
JP2004517081A (ja) * 2000-11-29 2004-06-10 イーライ・リリー・アンド・カンパニー １−（２−ｍ−メタンスルホンアミドフェニルエチル）−４−（ｍ−トリフルオロメチルフェニル）ピペラジンならびにその医薬的に許容しうる塩および溶媒和物
WO2003000664A1 (de) * 2001-06-22 2003-01-03 Bayer Aktiengesellschaft Uracilderivative und ihre verwendung bei der behandlung bakterieller erkrankungen
US20050058696A1 (en) * 2003-09-12 2005-03-17 Allergan, Inc. Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions
US20050059744A1 (en) * 2003-09-12 2005-03-17 Allergan, Inc. Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions
AU2004279336A1 (en) 2003-09-12 2005-04-21 Allergan, Inc. Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions
US20060264442A1 (en) * 2005-05-18 2006-11-23 Allergan, Inc. Methods for the treatment of ocular and neurodegenerative conditions in a mammal
CN101200451B (zh) * 2006-12-15 2010-12-15 重庆药友制药有限责任公司 一种盐酸乌拉地尔的制备方法
CN102295607B (zh) * 2011-06-16 2013-04-17 郑州大学 乌拉地尔的逆相转移催化制备方法
KR102638538B1 (ko) 2021-12-28 2024-02-20 주식회사 한서켐 우라피딜 제조 중간체의 제조방법
CN115477616A (zh) * 2022-09-27 2022-12-16 河北广祥制药有限公司 一种乌拉地尔杂质的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2567651A (en) * 1951-09-11 J-dialkyl-g-amino-l

Also Published As

Publication number Publication date
HK23678A (en) 1978-05-12
SU399130A3 (es) 1973-09-27
DE1942405B2 (de) 1973-10-31
FR2073300B1 (es) 1974-02-01
US3957786A (en) 1976-05-18
DE1942405A1 (de) 1971-09-16
IE35177B1 (en) 1975-12-10
IE35177L (en) 1971-02-20
GB1309324A (en) 1973-03-07
IL35121A (en) 1974-03-14
HU163664B (es) 1973-10-27
SU363248A3 (es) 1972-12-30
FI54479B (fi) 1978-08-31
NO129148B (es) 1974-03-04
BG17795A3 (es) 1973-12-25
YU207670A (en) 1982-02-25
SE386448B (sv) 1976-08-09
BE755015A (fr) 1971-02-01
YU36509B (en) 1984-02-29
CH582173A5 (es) 1976-11-30
YU36518B (en) 1984-02-29
BG17796A3 (es) 1973-12-25
DE1942405C3 (de) 1974-05-30
AT302359B (de) 1972-10-10
BR6915466D0 (pt) 1973-05-15
DK124031B (da) 1972-09-04
IL35121A0 (en) 1970-10-30
ZA705729B (en) 1972-03-29
CA956944A (en) 1974-10-29
LU61527A1 (es) 1971-06-22
FI54479C (fi) 1978-12-11
FR2073300A1 (es) 1971-10-01
YU203979A (en) 1982-02-25
CH551990A (de) 1974-07-31
NL155014B (nl) 1977-11-15
US4067982A (en) 1978-01-10
BG17585A3 (es) 1973-11-10
AT318651B (de) 1974-11-11
NL7012364A (es) 1971-02-23

Similar Documents

Publication Publication Date Title
ES382842A1 (es) Procedimiento para la preparacion de piperazinilalcohilami-no - uracilos, uracileteres y uraciltioeteres aril-sustitui-dos.
AU466722B2 (en) 1,2,4-triazole derivatives, process for their production and their use as fungicides
AU462239B2 (en) New phenyl-imidazolyl-alkanyl derivatives, their production and their pharmaceutical use
AU476126B2 (en) New triazine derivatives, their production and their medicinal use
ES352030A1 (es) Procedimiento de obtencion y purificacion de la uricasa.
ES414888A1 (es) Metodo de preparar compuestos triciclicos de azufre antia- lergicos.
CA1000713A (en) Aminophenylamidines, their production and their pharmaceutical use
ES343957A1 (es) Procedimiento de obtencion de polisacaridos sulfatados an- tilipemicos activos por via oral.
AU6053473A (en) Antimycotic compositions, medicaments and method
CA994340A (en) N-substituted imidazoles, their production and use
IL41614A0 (en) New insulin derivatives,their production and pharmaceutical compositions containing them
AU454611B2 (en) Thienyl-fattyacid derivatives processes for their production, and their use as therapeutic agents
AU2828071A (en) Ureidophenylisothioureas, process for their prepation, and their use as fungicides
ES386130A1 (es) Un procedimiento para preparar acido 2-(alfa - (p-clorofe- noxi) - isobutiril)-aminoetanosulfonico o su sal fisiologi- camente compatible.
AU453621B2 (en) Thriiodo-phenylalkyl ethers, their application in x-ray contrast agents and process for their production
AU5825873A (en) New 2-amino-4 h-pyrane compounds, their production, and their medicinal use
ES419982A1 (es) Procedimiento para la preparacion de 2-amino-2-oxazolinas.
AU452967B2 (en) New quinazolone derivatives, their production and their medicinal use
AU6242973A (en) New triazinyl derivatives, their production, and their pharmaceutical and veterinary use
AU458366B2 (en) New heterocyclic n. n-dioxides and their salts their production, and their medicinal use
CA897180A (en) Isothiocyano-diphenyl amines, process for their production and use thereof as anthelmintics
IL39285A0 (en) Imidazole derivatives,their production and pharmaceutical compositions containing them
ES404317A1 (es) Un procedimiento para la preparacion de sales 4-cloro-m-to-luensulfonicas o 3,4-diclorobenzosulfonicas.
CA820920A (en) Process for the production of new 5-sulphonyl-1, 2-dithiol-3-ones and their use for the combatting of fungi and bacteria
AU452313B2 (en) 1-(1,3,4-thiadiazo-2-yl) - imidazolidinone- (2) derivatives, process for their production and their use as herbicidal agents

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19920914